Literature DB >> 32072721

The stratification of cirrhosis.

James Maurice1, Massimo Pinzani1.   

Abstract

Cirrhosis is traditionally seen as an irreversible stage of chronic liver disease although its clinical course may last several years. Overall, the clinical management of patients with cirrhosis is based on the observation of clinical events mostly related to complications of portal hypertension. Each event of cirrhosis decompensation has clear prognostic implications although it is not precisely predictable. In practice, the advancement in the knowledge of the mechanisms responsible for disease progression is not yet translated in clinical tools allowing the stratification of the cirrhotic stage according to pathophysiological mechanisms. This article provides a review of the main clinical and histopathological features of liver cirrhosis that are relevant for its clinical stratification together with the advancements provided by the introduction of non-invasive measures of portal hypertension. Other clinical aspects that have a major impact on the quality of life and the possibility of liver transplantation are also discussed.
© 2020 The Japan Society of Hepatology.

Entities:  

Keywords:  cirrhosis; elastography; hepatic venous pressure gradient (HVPG); hepatocellular carcinoma (HCC); liver transplantation; sarcopenia

Year:  2020        PMID: 32072721     DOI: 10.1111/hepr.13493

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

Review 1.  Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis.

Authors:  Marija Branković; Igor Jovanović; Marija Dukić; Tijana Radonjić; Svetlana Oprić; Slobodan Klašnja; Marija Zdravković
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

3.  What Makes Cirrhosis Irreversible?-Consideration on Structural Changes.

Authors:  Katalin Dezső; Sándor Paku; László Kóbori; Snorri S Thorgeirsson; Péter Nagy
Journal:  Front Med (Lausanne)       Date:  2022-04-27

Review 4.  Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

Review 5.  Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.

Authors:  Frank Tacke; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2021-04

6.  Human Amnion-Derived Mesenchymal Stromal Cells in Cirrhotic Patients with Refractory Ascites: A Possible Anti-Inflammatory Therapy for Preventing Spontaneous Bacterial Peritonitis.

Authors:  Mariangela Pampalone; Simona Corrao; Giandomenico Amico; Giampiero Vitale; Rossella Alduino; Pier Giulio Conaldi; Giada Pietrosi
Journal:  Stem Cell Rev Rep       Date:  2021-01-03       Impact factor: 5.739

Review 7.  Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance.

Authors:  Siyer Roohani; Frank Tacke
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.